EN
DE
Home>Research>Publications

Publications

Using the search function, publications can be filtered according to the criteria "Author", "Keyword", "Journal" und "Year". Within the criteria, a link with "and" / "or" is possible.

Author
Keyword
Journal
Year

2018

  • Gamma secretase dependent release of the CD44 cytoplasmic tail upregulates IFI16 in cd44-/- tumor cells, MEFs and macrophages.
    Schultz* K, Grieger (Lindner)* C, Li Y, Urbánek P, Ruschel A, Minnich K, Bruder D, Gereke M, Sechi A, Herrlich P
    PLoS One 2018, 13(12), e0207358 * equal contribution
  • Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunities.
    Schulz A, Grafe P, Hagel C, Bäumer P, Morrison H, Mautner VF, Farschtschi S
    Exp Neurol 2018, 299(Pt B), 334-44
  • Regulation of RNA Polymerase I Transcription in Development, Disease, and Aging.
    Sharifi S, Bierhoff H
    Annu Rev Biochem 2018, 87, 51-73
  • Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins.
    Shende R, Wong SSW, Rapole S, Beau R, Ibrahim-Granet O, Monod M, Gührs KH, Pal JK, Latgé JP, Madan T, Aimanianda V, Sahu A
    J Biol Chem 2018, 293(40), 15538-55
  • The Definition of Open Reading Frame Revisited.
    Sieber P, Platzer M, Schuster S
    Trends Genet 2018, 34(3), 167-70
  • A Boolean network of the crosstalk between IGF and Wnt signaling in aging satellite cells.
    Siegle* L, Schwab* JD, Kühlwein* SD, Lausser L, Tümpel S, Pfister AS, Kühl** M, Kestler** HA
    PLoS One 2018, 13(3), e0195126 * equal contribution, ** co-senior authors
  • Generation and characterization of telomerase (tert) mutants in Nothobranchius furzeri.
    Singer P
    Dissertation 2018, Jena, Germany
  • The ATR-Activation Domain of TopBP1 Is Required for the Suppression of Origin Firing during the S Phase.
    Sokka* M, Koalick* D, Hemmerich P, Syväoja JE, Pospiech H
    Int J Mol Sci 2018, 19(8) * equal contribution
  • LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells.
    Sonnemann J, Zimmermann M, Marx C, Ebert F, Becker S, Lauterjung ML, Beck JF
    Br J Haematol 2018, 183(4), 494-7
  • Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.
    Synodos for NF2 Consortium, Allaway R, Angus SP, Beauchamp RL, Blakeley JO, Bott M, Burns SS, Carlstedt A, Chang LS, Chen X, Clapp DW, Desouza PA, Erdin S, Fernandez-Valle C, Guinney J, Gusella JF, Haggarty SJ, Johnson GL, La Rosa S, Morrison H, Petrilli AM, Plotkin SR, Pratap A, Ramesh V, Sciaky N, Stemmer-Rachamimov A, Stuhlmiller TJ, Talkowski ME, Welling DB, Yates CW, Zawistowski JS, Zhao WN
    PLoS One 2018, 13(6), e0197350